Pricelists.org Pricelists.org 로그인 가입하기

Teratogenicity Testing

☆☆☆☆☆ (0 reviews)
Show price history
Teratogenicity Testing
Lowest price (incl. delivery)
20 606,00 JPY
Typical price3 562,92 PLN
Lowest (90 days)127,50 PLN
Offers3
Last updated5일 전
See best offer
Price history (90 days)
Full history
2026-08-08 2026-08-15
가격 이력
업데이트 일시가격
2026-08-08127,50
2026-08-15170,00
판매자 Product price Delivery 합계 재고 여부 Updated
SP SpringerNatureLink Shop INT 20 591,00 JPY 15,00 JPY 20 606,00 JPY 구매 가능 5일 전 View offer
SP Springer Nature Author 20 591,00 JPY free 20 591,00 JPY 구매 가능 1주 전 View offer
SP SpringerNatureLink Shop INT 170,00 EUR 15,00 EUR 185,00 EUR 구매 가능 5일 전 View offer

가격과 재고 여부는 변경될 수 있습니다. 마지막 업데이트: 15.08.2026 06:21.

EAN 9781071636251
Springer Nature
0,0
☆☆☆☆☆
0 reviews
5★ 0%
4★ 0%
3★ 0%
2★ 0%
1★ 0%

Product reviews

Rating
No reviews yet — be the first!
This fully updated volume collects laboratory techniques and tests to assess the risks to embryo-fetal development from drug exposure during early developmental stages. Beginning with a section detailing basic principles of teratogenicity, the book continues with application of in vitro models for teratogenic screening to predict toxicity in embryonic animals and humans, as well as a variety of well-established in vivo animal model tests, which offer solutions for evaluating the efficacy and the teratogenicity of compounds in preclinical trials before human safety testing. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Teratogenicity Testing: Methods and Protocols, Second Edition serves as an ideal guide to tests that can be performed in cells, organs, tissues, and animal models for evaluating toxicity and/or safety of compounds in early developmental stages with the goal of estimating, preventing, or minimizing the teratogenic potential of drugs.

Similar products